182 related articles for article (PubMed ID: 28830475)
1. Preoperative intensity-modulated radiotherapy with a simultaneous integrated boost combined with Capecitabine in locally advanced rectal cancer: short-term results of a multicentric study.
Lupattelli M; Matrone F; Gambacorta MA; Osti M; Macchia G; Palazzari E; Nicosia L; Navarria F; Chiloiro G; Valentini V; Aristei C; De Paoli A
Radiat Oncol; 2017 Aug; 12(1):139. PubMed ID: 28830475
[TBL] [Abstract][Full Text] [Related]
2. Preoperative Intensified Chemoradiation with Intensity-Modulated Radiotherapy and Simultaneous Integrated Boost Combined with Capecitabine in Locally Advanced Rectal Cancer: Long-Term Outcomes of a Real-Life Multicenter Study.
Lupattelli M; Palazzari E; Polesel J; Chiloiro G; Angelicone I; Panni V; Caravatta L; Di Biase S; Macchia G; Niespolo RM; Franco P; Epifani V; Meldolesi E; de Giacomo F; Lucarelli M; Montesi G; Mantello G; Innocente R; Osti MF; Gambacorta MA; Aristei C; De Paoli A
Cancers (Basel); 2023 Dec; 15(23):. PubMed ID: 38067405
[TBL] [Abstract][Full Text] [Related]
3. Acute Toxicity and Tumor Response in Locally Advanced Rectal Cancer After Preoperative Chemoradiation Therapy With Shortening of the Overall Treatment Time Using Intensity-Modulated Radiation Therapy With Simultaneous Integrated Boost: A Phase 2 Trial.
But-Hadzic J; Anderluh F; Brecelj E; Edhemovic I; Secerov-Ermenc A; Hudej R; Jeromen A; Kozelj M; Krebs B; Oblak I; Omejc M; Vogrin A; Velenik V
Int J Radiat Oncol Biol Phys; 2016 Dec; 96(5):1003-1010. PubMed ID: 27727065
[TBL] [Abstract][Full Text] [Related]
4. A phase II trial of neoadjuvant IMRT-based chemoradiotherapy followed by one cycle of capecitabine for stage II/III rectal adenocarcinoma.
Zhu J; Gu W; Lian P; Sheng W; Cai G; Shi D; Cai S; Zhang Z
Radiat Oncol; 2013 May; 8():130. PubMed ID: 23718210
[TBL] [Abstract][Full Text] [Related]
5. Concomitant boost IMRT-based neoadjuvant chemoradiotherapy for clinical stage II/III rectal adenocarcinoma: results of a phase II study.
Zhu J; Liu F; Gu W; Lian P; Sheng W; Xu J; Cai G; Shi D; Cai S; Zhang Z
Radiat Oncol; 2014 Mar; 9():70. PubMed ID: 24606870
[TBL] [Abstract][Full Text] [Related]
6. [Analysis on efficacy and safety of total neoadjuvant therapy in patients with locally advanced rectal cancer with high risk factors].
Ouyang GL; Meng WJ; Shu P; Deng XB; Wu B; Jiang D; Zhuang H; Shen YL; Zhou ZG; Wang ZQ; Wang X
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Apr; 22(4):349-356. PubMed ID: 31054549
[No Abstract] [Full Text] [Related]
7. Preoperative Chemoradiation With VMAT-SIB in Rectal Cancer: A Phase II Study.
Picardi V; Macchia G; Guido A; Giaccherini L; Deodato F; Farioli A; Cilla S; Compagnone G; Ardizzoni A; Cuicchi D; Gambacorta MA; Cellini F; Frezza G; Poggioli G; Valentini V; Fuccio L; Morganti AG
Clin Colorectal Cancer; 2017 Mar; 16(1):16-22. PubMed ID: 27435759
[TBL] [Abstract][Full Text] [Related]
8. Preoperative Volumetric Modulated Arc Therapy With Simultaneous Integrated Boost for Locally Advanced Distal Rectal Cancer.
Yang Y; Liu Q; Jia B; Du X; Dai G; Liu H; Chen J; Zeng M; Wen K; Zhu Y; Wang Y; Feng L
Technol Cancer Res Treat; 2019 Jan; 18():1533033818824367. PubMed ID: 30803368
[TBL] [Abstract][Full Text] [Related]
9. Comparison of volumetric-modulated arc therapy using simultaneous integrated boosts (SIB-VMAT) of 45 Gy/55 Gy in 25 fractions with conventional radiotherapy in preoperative chemoradiation for rectal cancers: a propensity score case-matched analysis.
Yamashita H; Ishihara S; Nozawa H; Kawai K; Kiyomatsu T; Okuma K; Abe O; Watanabe T; Nakagawa K
Radiat Oncol; 2017 Sep; 12(1):156. PubMed ID: 28934968
[TBL] [Abstract][Full Text] [Related]
10. Phase I trial of preoperative hypofractionated intensity-modulated radiotherapy with incorporated boost and oral capecitabine in locally advanced rectal cancer.
Freedman GM; Meropol NJ; Sigurdson ER; Hoffman J; Callahan E; Price R; Cheng J; Cohen S; Lewis N; Watkins-Bruner D; Rogatko A; Konski A
Int J Radiat Oncol Biol Phys; 2007 Apr; 67(5):1389-93. PubMed ID: 17394942
[TBL] [Abstract][Full Text] [Related]
11. Four-week neoadjuvant intensity-modulated radiation therapy with concurrent capecitabine and oxaliplatin in locally advanced rectal cancer patients: a validation phase II trial.
Arbea L; Martínez-Monge R; Díaz-González JA; Moreno M; Rodríguez J; Hernández JL; Sola JJ; Ramos LI; Subtil JC; Nuñez J; Chopitea A; Cambeiro M; Gaztañaga M; García-Foncillas J; Aristu J
Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):587-93. PubMed ID: 22079731
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of neoadjuvant intensity-modulated radiotherapy with concurrent capecitabine for locally advanced rectal cancer.
Wang L; Li ZY; Li ZW; Li YH; Sun YS; Ji JF; Gu J; Cai Y
Dis Colon Rectum; 2015 Feb; 58(2):186-92. PubMed ID: 25585076
[TBL] [Abstract][Full Text] [Related]
13. A Dosimetric Analysis of Preoperative Intensity-modulated and Image-guided Radiation Therapy with and without Simultaneous Integrated Boost for Locally Advanced Rectal Cancer.
Yang Y; Feng L; Wang Y; Ge R; Gong H; Xie C; Wang J; Chen J; Lan Y; Ma L
Technol Cancer Res Treat; 2015 Oct; 14(5):557-63. PubMed ID: 24988052
[TBL] [Abstract][Full Text] [Related]
14. Complete pathological responses in locally advanced rectal cancer after preoperative IMRT and integrated-boost chemoradiation.
Hernando-Requejo O; López M; Cubillo A; Rodriguez A; Ciervide R; Valero J; Sánchez E; Garcia-Aranda M; Rodriguez J; Potdevin G; Rubio C
Strahlenther Onkol; 2014 Jun; 190(6):515-20. PubMed ID: 24715243
[TBL] [Abstract][Full Text] [Related]
15. Postoperative Capecitabine with Concurrent Intensity-Modulated Radiotherapy or Three-Dimensional Conformal Radiotherapy for Patients with Stage II and III Rectal Cancer.
Lu NN; Jin J; Wang SL; Wang WH; Song YW; Liu YP; Ren H; Fang H; Liu XF; Yu ZH; Li YX
PLoS One; 2015; 10(4):e0124601. PubMed ID: 25915948
[TBL] [Abstract][Full Text] [Related]
16. Phase II trial of concomitant neoadjuvant chemotherapy with oxaliplatin and capecitabine and intensity-modulated radiotherapy (IMRT) in rectal cancer.
Gasent Blesa JM; Garde Noguera J; Laforga Canales JB; Giner Bosch V; Alberola A; Soler Tortosa M; Peris Godoy M; Sanchez JL; Provencio Pulla M; Alberola Candel V
J Gastrointest Cancer; 2012 Dec; 43(4):553-61. PubMed ID: 22371167
[TBL] [Abstract][Full Text] [Related]
17. Phase II trial of preoperative radiochemotherapy with concurrent bevacizumab, capecitabine and oxaliplatin in patients with locally advanced rectal cancer.
Dellas K; Höhler T; Reese T; Würschmidt F; Engel E; Rödel C; Wagner W; Richter M; Arnold D; Dunst J
Radiat Oncol; 2013 Apr; 8():90. PubMed ID: 23587311
[TBL] [Abstract][Full Text] [Related]
18. Radiation dose intensification in pre-operative chemo-radiotherapy for locally advanced rectal cancer.
Alongi F; Fersino S; Mazzola R; Fiorentino A; Giaj-Levra N; Ricchetti F; Ruggieri R; Di Paola G; Cirillo M; Gori S; Salgarello M; Zamboni G; Ruffo G
Clin Transl Oncol; 2017 Feb; 19(2):189-196. PubMed ID: 27271749
[TBL] [Abstract][Full Text] [Related]
19. Retrospective Evaluation of the Impact of Dose Escalation Using Pre-operative Simultaneous Integrated Boost Volumetric Modulated Arc Therapy on the Outcome of Locally Advanced Rectal Cancer Patients.
Elashwah A; Alsuhaibani A; Abduljabbar A; Alsanea N; Alhomoud S; Ashari L; Bazarbashi S; Aljubran A; Alzahrani A; Awad A; Almanea H; Alhussini H; Alshabanah M
J Gastrointest Cancer; 2023 Sep; 54(3):927-936. PubMed ID: 36525233
[TBL] [Abstract][Full Text] [Related]
20. CAPIRI-IMRT: a phase II study of concurrent capecitabine and irinotecan with intensity-modulated radiation therapy for the treatment of recurrent rectal cancer.
Cai G; Zhu J; Palmer JD; Xu Y; Hu W; Gu W; Cai S; Zhang Z
Radiat Oncol; 2015 Feb; 10():57. PubMed ID: 25889149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
